TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs809871
log Bayes Factor = 86.3533
Chromosome 6   position 26,256,526  (GRCh37) Explore rs809871 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.999 0.001 0.000
K90 Intestinal malabsorption
0.000 0.528 0.472
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.620 0.380
K90.8 Other intestinal malabsorption
0.000 0.625 0.375
K90.3 Pancreatic steatorrhoea
0.000 0.661 0.338
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.661 0.338
K90.1 Tropical sprue
0.000 0.661 0.338
K90.9 Intestinal malabsorption, unspecified
0.000 0.756 0.243
I83 Varicose veins of lower extremities
0.197 0.803 0.000
E83 Disorders of mineral metabolism
0.176 0.824 0.000
I83.0 Varicose veins of lower extremities with ulcer
0.158 0.842 0.000
E83.3 Disorders of phosphorus metabolism
0.142 0.858 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.140 0.860 0.000
E83.8 Other disorders of mineral metabolism
0.126 0.874 0.000
E83.2 Disorders of zinc metabolism
0.126 0.874 0.000
E83.0 Disorders of copper metabolism
0.126 0.874 0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation
0.092 0.908 0.000
K51.2 Ulcerative (chronic) proctitis
0.073 0.927 0.000
I83.1 Varicose veins of lower extremities with inflammation
0.072 0.928 0.000
E83.4 Disorders of magnesium metabolism
0.066 0.934 0.000
K51 Ulcerative colitis
0.057 0.943 0.000
J92.9 Pleural plaque without asbestos
0.000 0.944 0.056
K51.3 Ulcerative (chronic) rectosigmoiditis
0.054 0.946 0.000
T39.1 4-Aminophenol derivatives
0.053 0.947 0.000
K51.0 Ulcerative (chronic) enterocolitis
0.050 0.950 0.000
Z72.0 Tobacco use
0.046 0.954 0.000
K51.4 Pseudopolyposis of colon
0.042 0.958 0.000
K51.1 Ulcerative (chronic) ileocolitis
0.041 0.959 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.039 0.961 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.038 0.962 0.000
K51.9 Ulcerative colitis, unspecified
0.037 0.963 0.000
K51.5 Mucosal proctocolitis
0.037 0.963 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.035 0.965 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.033 0.967 0.000
T40.2 Other opioids
0.033 0.967 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.033 0.967 0.000
T36 Poisoning by systemic antibiotics
0.032 0.968 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.031 0.969 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.031 0.969 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.031 0.969 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.030 0.970 0.000
K90-K93 Other diseases of the digestive system
0.000 0.971 0.029
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.029 0.971 0.000
T39.4 Antirheumatics, not elsewhere classified
0.028 0.972 0.000
T39.2 Pyrazolone derivatives
0.028 0.972 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.028 0.972 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.028 0.972 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.028 0.972 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.028 0.972 0.000
T42.0 Hydantoin derivatives
0.027 0.973 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.027 0.973 0.000
T45.5 Anticoagulants
0.027 0.973 0.000
J92 Pleural plaque
0.000 0.973 0.027
T41 Poisoning by anaesthetics and therapeutic gases
0.027 0.973 0.000
H43.3 Other vitreous opacities
0.000 0.973 0.027
T47.1 Other antacids and anti-gastric-secretion drugs
0.026 0.974 0.000
T36.3 Macrolides
0.026 0.974 0.000
H43.1 Vitreous haemorrhage
0.000 0.974 0.026
T36.8 Other systemic antibiotics
0.025 0.975 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.025 0.975 0.000
T40.5 Cocaine
0.025 0.975 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.025 0.975 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.025 0.975 0.000
T40.8 Lysergide [LSD]
0.025 0.975 0.000
T40.7 Cannabis (derivatives)
0.025 0.975 0.000
T40.3 Methadone
0.025 0.975 0.000
T40.0 Opium
0.025 0.975 0.000
T40.1 Heroin
0.025 0.975 0.000
T40.4 Other synthetic narcotics
0.025 0.975 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.025 0.975 0.000
O63.1 Prolonged second stage (of labour)
0.025 0.975 0.000
T36.4 Tetracyclines
0.025 0.975 0.000
T42.1 Iminostilbenes
0.025 0.975 0.000
H43 Disorders of vitreous body
0.000 0.975 0.025
T45.0 Antiallergic and antiemetic drugs
0.024 0.975 0.000
T42.4 Benzodiazepines
0.025 0.975 0.000
T47.0 Histamine H(2)-receptor antagonists
0.024 0.976 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.024 0.976 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.024 0.976 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.024 0.976 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.024 0.976 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.024 0.976 0.000
T44.0 Anticholinesterase agents
0.024 0.976 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.024 0.976 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.024 0.976 0.000
T42.3 Barbiturates
0.024 0.976 0.000
T42.2 Succinimides and oxazolidinediones
0.024 0.976 0.000
T48.5 Anti-common-cold drugs
0.023 0.977 0.000
T47.6 Antidiarrhoeal drugs
0.023 0.977 0.000
T36.9 Systemic antibiotic, unspecified
0.023 0.977 0.000
T36.7 Antifungal antibiotics, systemically used
0.023 0.977 0.000
T36.6 Rifamycins
0.023 0.977 0.000
T36.5 Aminoglycosides
0.023 0.977 0.000
T36.2 Chloramphenicol group
0.023 0.977 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.023 0.977 0.000
K50-K52 Noninfective enteritis and colitis
0.023 0.977 0.000
T40.6 Other and unspecified narcotics
0.022 0.977 0.000
T45.2 Vitamins, not elsewhere classified
0.022 0.978 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.022 0.978 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.022 0.978 0.000
T47.7 Emetics
0.022 0.978 0.000
T47.5 Digestants
0.022 0.978 0.000
T47.3 Saline and osmotic laxatives
0.022 0.978 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.022 0.978 0.000
T45.8 Other primarily systemic and haematological agents
0.022 0.978 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.022 0.978 0.000
T45.6 Fibrinolysis-affecting drugs
0.022 0.978 0.000
T45.4 Iron and its compounds
0.022 0.978 0.000
T45.3 Enzymes, not elsewhere classified
0.022 0.978 0.000
T36.0 Penicillins
0.021 0.978 0.000
T47.2 Stimulant laxatives
0.021 0.978 0.000
K50.8 Other Crohn's disease
0.021 0.979 0.000
K51.8 Other ulcerative colitis
0.021 0.979 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.021 0.979 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.021 0.979 0.000
J92.0 Pleural plaque with presence of asbestos
0.000 0.979 0.021
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.021 0.979 0.000
K50 Crohn's disease [regional enteritis]
0.021 0.979 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.979 0.021
T37.8 Other specified systemic anti-infectives and antiparasitics
0.021 0.979 0.000
T43.9 Psychotropic drug, unspecified
0.021 0.979 0.000
T47.4 Other laxatives
0.020 0.979 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.020 0.980 0.000
T48.4 Expectorants
0.020 0.980 0.000
T48.3 Antitussives
0.020 0.980 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.020 0.980 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.020 0.980 0.000
T48.0 Oxytocic drugs
0.020 0.980 0.000
T49.9 Topical agent, unspecified
0.020 0.980 0.000
T49.8 Other topical agents
0.020 0.980 0.000
T49.7 Dental drugs, topically applied
0.020 0.980 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.020 0.980 0.000
T49.5 Ophthalmological drugs and preparations
0.020 0.980 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.020 0.980 0.000
T49.3 Emollients, demulcents and protectants
0.020 0.980 0.000
T49.2 Local astringents and local detergents
0.020 0.980 0.000
T49.1 Antipruritics
0.020 0.980 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.020 0.980 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.020 0.980 0.000
T37.5 Antiviral drugs
0.020 0.980 0.000
T37.4 Anthelminthics
0.020 0.980 0.000
T37.3 Other antiprotozoal drugs
0.020 0.980 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.020 0.980 0.000
T37.1 Antimycobacterial drugs
0.020 0.980 0.000
T37.0 Sulphonamides
0.020 0.980 0.000
H43.9 Disorder of vitreous body, unspecified
0.000 0.980 0.020
T41.5 Therapeutic gases
0.020 0.980 0.000
T41.4 Anaesthetic, unspecified
0.020 0.980 0.000
T41.3 Local anaesthetics
0.020 0.980 0.000
T41.2 Other and unspecified general anaesthetics
0.020 0.980 0.000
T41.1 Intravenous anaesthetics
0.020 0.980 0.000
T41.0 Inhaled anaesthetics
0.020 0.980 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.019 0.981 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.019 0.981 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.019 0.981 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.019 0.981 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.019 0.981 0.000
H43.2 Crystalline deposits in vitreous body
0.000 0.981 0.019
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.018 0.981 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.018 0.982 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.018 0.982 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.018 0.982 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.018 0.982 0.000
T46.7 Peripheral vasodilators
0.018 0.982 0.000
Z72 Problems related to lifestyle
0.018 0.982 0.000
M43.16 Spondylolisthesis (Lumbar region)
0.018 0.982 0.000
R79.0 Abnormal level of blood mineral
0.018 0.982 0.000
H43.8 Other disorders of vitreous body
0.000 0.982 0.018
T43.2 Other and unspecified antidepressants
0.018 0.982 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.017 0.983 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.017 0.983 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.016 0.983 0.000
H43.0 Vitreous prolapse
0.000 0.983 0.016
K50.0 Crohn's disease of small intestine
0.017 0.983 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.016 0.984 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.016 0.984 0.000
T43.6 Psychostimulants with abuse potential
0.016 0.984 0.000
T50.1 Loop [high-ceiling] diuretics
0.016 0.984 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.016 0.984 0.000
T50.7 Analeptics and opioid receptor antagonists
0.015 0.984 0.000
T50.5 Appetite depressants
0.015 0.984 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.015 0.984 0.000
T50.0 Mineralocorticoids and their antagonists
0.015 0.984 0.000
T38.9 Other and unspecified hormone antagonists
0.015 0.985 0.000
T38.7 Androgens and anabolic congeners
0.015 0.985 0.000
T38.5 Other oestrogens and progestogens
0.015 0.985 0.000
T38.4 Oral contraceptives
0.015 0.985 0.000
T38.2 Antithyroid drugs
0.015 0.985 0.000
T38.0 Glucocorticoids and synthetic analogues
0.015 0.985 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.015 0.985 0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.985 0.015
K93.1 Megacolon in Chagas' disease
0.000 0.985 0.015
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.985 0.015
Z72.1 Alcohol use
0.015 0.985 0.000
T50.8 Diagnostic agents
0.015 0.985 0.000
T50.4 Drugs affecting uric acid metabolism
0.015 0.985 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.015 0.985 0.000
O48 Prolonged pregnancy
0.015 0.985 0.000
E83.5 Disorders of calcium metabolism
0.014 0.986 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.014 0.986 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.014 0.986 0.000
T46.1 Calcium-channel blockers
0.014 0.986 0.000
T38.1 Thyroid hormones and substitutes
0.014 0.986 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.014 0.986 0.000
K50.1 Crohn's disease of large intestine
0.014 0.986 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.013 0.986 0.000
T39.0 Salicylates
0.013 0.987 0.000
Z57.5 Occupational exposure to toxic agents in other industries
0.000 0.987 0.013
Z72.4 Inappropriate diet and eating habits
0.013 0.987 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.013 0.987 0.000
Z72.6 Gambling and betting
0.013 0.987 0.000
Z72.5 High-risk sexual behaviour
0.013 0.987 0.000
Z72.3 Lack of physical exercise
0.013 0.987 0.000
Z57.3 Occupational exposure to other air contaminants
0.000 0.987 0.013
Z57 Occupational exposure to risk-factors
0.000 0.988 0.012
Z72.9 Problem related to lifestyle, unspecified
0.012 0.988 0.000
Z57.2 Occupational exposure to dust
0.000 0.988 0.012
Z72.2 Drug use
0.011 0.989 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.011 0.989 0.000
K50.9 Crohn's disease, unspecified
0.010 0.990 0.000
Z72.8 Other problems related to lifestyle
0.009 0.990 0.000
E70-E90 Metabolic disorders
0.009 0.991 0.000
O69.2 Labour and delivery complicated by other cord entanglement
0.009 0.991 0.000
C64 Malignant neoplasm of kidney, except renal pelvis
0.009 0.991 0.000
R79 Other abnormal findings of blood chemistry
0.009 0.991 0.000
Z57.9 Occupational exposure to unspecified risk-factor
0.000 0.991 0.009
Z57.7 Occupational exposure to vibration
0.000 0.991 0.009
Z57.6 Occupational exposure to extreme temperature
0.000 0.991 0.009
Z57.4 Occupational exposure to toxic agents in agriculture
0.000 0.991 0.009
Z57.1 Occupational exposure to radiation
0.000 0.991 0.009
Z57.0 Occupational exposure to noise
0.000 0.991 0.009
E85 Amyloidosis
0.009 0.991 0.000
M43.1 Spondylolisthesis
0.009 0.991 0.000
R79.9 Abnormal finding of blood chemistry, unspecified
0.008 0.992 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.008 0.992 0.000
E85.9 Amyloidosis, unspecified
0.008 0.992 0.000
E85.8 Other amyloidosis
0.008 0.992 0.000
E88 Other metabolic disorders
0.008 0.992 0.000
E80.1 Porphyria cutanea tarda
0.007 0.992 0.000
E72 Other disorders of amino-acid metabolism
0.007 0.993 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.007 0.993 0.000
E85.3 Secondary systemic amyloidosis
0.007 0.993 0.000
E84 Cystic fibrosis
0.007 0.993 0.000
E70 Disorders of aromatic amino-acid metabolism
0.007 0.993 0.000
E73 Lactose intolerance
0.007 0.993 0.000
Z57.8 Occupational exposure to other risk-factors
0.000 0.993 0.007
E77 Disorders of glycoprotein metabolism
0.007 0.993 0.000
E76 Disorders of glycosaminoglycan metabolism
0.007 0.993 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.007 0.993 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.007 0.993 0.000
G25.8 Other specified extrapyramidal and movement disorders
0.007 0.993 0.000
M43.12 Spondylolisthesis (Cervical region)
0.007 0.993 0.000
Z43.1 Attention to gastrostomy
0.007 0.993 0.000
D36.1 Peripheral nerves and autonomic nervous system
0.007 0.993 0.000
E80.2 Other porphyria
0.007 0.993 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.007 0.993 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.007 0.993 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.007 0.993 0.000
E88.8 Other specified metabolic disorders
0.007 0.993 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.007 0.993 0.000
E74 Other disorders of carbohydrate metabolism
0.006 0.993 0.000
G59.0 Diabetic mononeuropathy
0.007 0.993 0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.006 0.994 0.000
M43.15 Spondylolisthesis (Thoracolumbar region)
0.006 0.994 0.000
M43.14 Spondylolisthesis (Thoracic region)
0.006 0.994 0.000
M43.13 Spondylolisthesis (Cervicothoracic region)
0.006 0.994 0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.006 0.994 0.000
E79 Disorders of purine and pyrimidine metabolism
0.006 0.994 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.006 0.994 0.000
R40.0 Somnolence
0.000 0.994 0.006
M10.96 Gout, unspecified (Lower leg)
0.000 0.994 0.006
M43.10 Spondylolisthesis (Multiple sites in spine)
0.006 0.994 0.000
E75.2 Other sphingolipidosis
0.006 0.994 0.000
E80.6 Other disorders of bilirubin metabolism
0.006 0.994 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.006 0.994 0.000
E80.5 Crigler-Najjar syndrome
0.006 0.994 0.000
E80.3 Defects of catalase and peroxydase
0.006 0.994 0.000
E80.0 Hereditary erythropoietic porphyria
0.006 0.994 0.000
E85.4 Organ-limited amyloidosis
0.006 0.994 0.000
E72.0 Disorders of amino-acid transport
0.006 0.994 0.000
E88.3 Tumour lysis syndrome
0.006 0.994 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.006 0.994 0.000
Z76.3 Healthy person accompanying sick person
0.006 0.994 0.000
Z76 Persons encountering health services in other circumstances
0.006 0.994 0.000
E70.3 Albinism
0.006 0.994 0.000
H43-H45 Disorders of vitreous body and globe
0.000 0.994 0.006
E72.9 Disorder of amino-acid metabolism, unspecified
0.005 0.994 0.000
E72.8 Other specified disorders of amino-acid metabolism
0.005 0.994 0.000
E72.5 Disorders of glycine metabolism
0.005 0.994 0.000
E72.4 Disorders of ornithine metabolism
0.005 0.994 0.000
E72.3 Disorders of lysine and hydroxylysine metabolism
0.005 0.994 0.000
E72.2 Disorders of urea cycle metabolism
0.005 0.994 0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.005 0.994 0.000
E75.6 Lipid storage disorder, unspecified
0.005 0.994 0.000
E75.4 Neuronal ceroid lipofuscinosis
0.005 0.994 0.000
E75.3 Sphingolipidosis, unspecified
0.005 0.994 0.000
E75.1 Other gangliosidosis
0.005 0.994 0.000
E75.0 GM2 gangliosidosis
0.005 0.994 0.000
E73.9 Lactose intolerance, unspecified
0.005 0.994 0.000
E84.8 Cystic fibrosis with other manifestations
0.005 0.994 0.000
E84.1 Cystic fibrosis with intestinal manifestations
0.005 0.994 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.005 0.995 0.000
E70.8 Other disorders of aromatic amino-acid metabolism
0.005 0.995 0.000
E70.2 Disorders of tyrosine metabolism
0.005 0.995 0.000
E70.1 Other hyperphenylalaninaemias
0.005 0.995 0.000
E70.0 Classical phenylketonuria
0.005 0.995 0.000
D32.9 Meninges, unspecified
0.000 0.995 0.005
E73.8 Other lactose intolerance
0.005 0.995 0.000
E73.1 Secondary lactase deficiency
0.005 0.995 0.000
E73.0 Congenital lactase deficiency
0.005 0.995 0.000
G25.3 Myoclonus
0.005 0.995 0.000
M43 Other deforming dorsopathies
0.005 0.995 0.000
D37.1 Stomach
0.005 0.995 0.000
E84.9 Cystic fibrosis, unspecified
0.005 0.995 0.000
E71.3 Disorders of fatty-acid metabolism
0.005 0.995 0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.005 0.995 0.000
E71.1 Other disorders of branched-chain amino-acid metabolism
0.005 0.995 0.000
E71.0 Maple-syrup-urine disease
0.005 0.995 0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.005 0.995 0.000
E76.8 Other disorders of glucosaminoglycan metabolism
0.005 0.995 0.000
E76.3 Mucopolysaccharidosis, unspecified
0.005 0.995 0.000
E76.2 Other mucopolysaccharidoses
0.005 0.995 0.000
E76.1 Mucopolysaccharidosis, type II
0.005 0.995 0.000
E76.0 Mucopolysaccharidosis, type I
0.005 0.995 0.000
E77.9 Disorder of glycoprotein metabolism, unspecified
0.005 0.995 0.000
E77.8 Other disorders of glycoprotein metabolism
0.005 0.995 0.000
E77.1 Defects in glycoprotein degradation
0.005 0.995 0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.005 0.995 0.000
Z70-Z76 Persons encountering health services in other circumstances
0.005 0.995 0.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.995 0.005
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified
0.000 0.995 0.005
E75.5 Other lipid storage disorders
0.005 0.995 0.000
R79.8 Other specified abnormal findings of blood chemistry
0.005 0.995 0.000
M43.19 Spondylolisthesis (Site unspecified)
0.005 0.995 0.000
D75.1 Secondary polycythaemia
0.005 0.995 0.000
X51.9 Unspecified place
0.005 0.995 0.000
G25 Other extrapyramidal and movement disorders
0.005 0.995 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.005 0.995 0.000
E74.8 Other specified disorders of carbohydrate metabolism
0.005 0.995 0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.005 0.995 0.000
E74.2 Disorders of galactose metabolism
0.005 0.995 0.000
E74.1 Disorders of fructose metabolism
0.005 0.995 0.000
E74.0 Glycogen storage disease
0.005 0.995 0.000
Z76.8 Persons encountering health services in other specified circumstances
0.005 0.995 0.000
X50.4 Street and highway
0.005 0.995 0.000
M43.17 Spondylolisthesis (Lumbosacral region)
0.005 0.995 0.000
D37.7 Other digestive organs
0.005 0.995 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.005 0.995 0.000
E79.8 Other disorders of purine and pyrimidine metabolism
0.005 0.995 0.000
E79.1 Lesch-Nyhan syndrome
0.005 0.995 0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.005 0.995 0.000
E88.9 Metabolic disorder, unspecified
0.005 0.995 0.000
S02.80 Fractures of other skull and facial bones (closed)
0.000 0.995 0.005
D37.4 Colon
0.005 0.995 0.000
M43.0 Spondylolysis
0.005 0.995 0.000
D37.6 Liver, gallbladder and bile ducts
0.005 0.995 0.000
X50 Overexertion and strenuous or repetitive movements
0.005 0.995 0.000
Z46.6 Fitting and adjustment of urinary device
0.005 0.995 0.000
E80.4 Gilbert's syndrome
0.005 0.995 0.000
D36 Benign neoplasm of other and unspecified sites
0.005 0.995 0.000
E74.3 Other disorders of intestinal carbohydrate absorption
0.004 0.996 0.000
X51 Travel and motion
0.004 0.996 0.000
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)
0.004 0.996 0.000
Z22.3 Carrier of other specified bacterial diseases
0.004 0.996 0.000
Z76.9 Persons encountering health services in unspecified circumstances
0.004 0.996 0.000
Z76.5 Malingerer [conscious situation]
0.004 0.996 0.000
Z76.4 Other boarder in health-care facility
0.004 0.996 0.000
Z76.2 Health supervision and care of other healthy infant and child
0.004 0.996 0.000
Z76.1 Health supervision and care of foundling
0.004 0.996 0.000
Z76.0 Issue of repeat prescription
0.004 0.996 0.000
Z74.2 Need for assistance at home and no other household member able to render care
0.004 0.996 0.000
Z70 Counselling related to sexual attitude, behaviour and orientation
0.004 0.996 0.000
D37.3 Appendix
0.004 0.996 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.004 0.996 0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.996 0.004
E88.2 Lipomatosis, not elsewhere classified
0.004 0.996 0.000
M43.6 Torticollis
0.004 0.996 0.000
M43.2 Other fusion of spine
0.004 0.996 0.000
Z74 Problems related to care-provider dependency
0.004 0.996 0.000
G25.1 Drug-induced tremor
0.004 0.996 0.000
D36.0 Lymph nodes
0.004 0.996 0.000
M43.8 Other specified deforming dorsopathies
0.004 0.996 0.000
M43.5 Other recurrent vertebral subluxation
0.004 0.996 0.000
M43.4 Other recurrent atlantoaxial subluxation
0.004 0.996 0.000
M43.3 Recurrent atlantoaxial subluxation with myelopathy
0.004 0.996 0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue
0.004 0.996 0.000
S32.40 Fracture of acetabulum (closed)
0.000 0.996 0.004
M66.24 Spontaneous rupture of extensor tendons (Hand)
0.004 0.996 0.000
X50.2 School, other institution and public administrative area
0.004 0.996 0.000
Z93.3 Colostomy status
0.004 0.996 0.000
G25.0 Essential tremor
0.004 0.996 0.000
M43.9 Deforming dorsopathy, unspecified
0.004 0.996 0.000
X50.6 Industrial and construction area
0.004 0.996 0.000
G25.6 Drug-induced tics and other tics of organic origin
0.004 0.996 0.000
G25.4 Drug-induced chorea
0.004 0.996 0.000
Q43.8 Other specified congenital malformations of intestine
0.000 0.996 0.004
M43.07 Spondylolysis (Lumbosacral region)
0.004 0.996 0.000
Z75 Problems related to medical facilities and other health care
0.004 0.996 0.000
Z75.1 Person awaiting admission to adequate facility elsewhere
0.004 0.996 0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M43.09 Spondylolysis (Site unspecified)
0.004 0.996 0.000
D36.7 Other specified sites
0.004 0.996 0.000
D37.9 Digestive organ, unspecified
0.004 0.996 0.000
D45 Polycythaemia vera
0.004 0.996 0.000
X50-X57 Overexertion, travel and privation
0.004 0.996 0.000
M43.02 Spondylolysis (Cervical region)
0.004 0.996 0.000
Z70.1 Counselling related to patient's sexual behaviour and orientation
0.004 0.996 0.000
Q43 Other congenital malformations of intestine
0.000 0.996 0.004
Z74.3 Need for continuous supervision
0.003 0.996 0.000
M43.05 Spondylolysis (Thoracolumbar region)
0.003 0.996 0.000
M43.04 Spondylolysis (Thoracic region)
0.003 0.996 0.000
M43.03 Spondylolysis (Cervicothoracic region)
0.003 0.996 0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)
0.003 0.996 0.000
M43.00 Spondylolysis (Multiple sites in spine)
0.003 0.996 0.000
X50.9 Unspecified place
0.003 0.996 0.000
X50.8 Other specified place
0.003 0.996 0.000
X50.5 Trade and service area
0.003 0.996 0.000
X50.3 Sports and athletics area
0.003 0.996 0.000
X50.0 Home
0.003 0.996 0.000
X50.7 Farm
0.003 0.996 0.000
X50.1 Residential institution
0.003 0.996 0.000
X51.8 Other specified place
0.003 0.996 0.000
O26.8 Other specified pregnancy-related conditions
0.004 0.996 0.000
M43.26 Other fusion of spine (Lumbar region)
0.003 0.996 0.000
D36.9 Benign neoplasm of unspecified site
0.003 0.996 0.000
G25.2 Other specified forms of tremor
0.003 0.997 0.000
X51.7 Farm
0.003 0.997 0.000
X51.6 Industrial and construction area
0.003 0.997 0.000
X51.5 Trade and service area
0.003 0.997 0.000
X51.4 Street and highway
0.003 0.997 0.000
X51.3 Sports and athletics area
0.003 0.997 0.000
X51.2 School, other institution and public administrative area
0.003 0.997 0.000
X51.1 Residential institution
0.003 0.997 0.000
X51.0 Home
0.003 0.997 0.000
Z74.9 Problem related to care-provider dependency, unspecified
0.003 0.997 0.000
Z74.1 Need for assistance with personal care
0.003 0.997 0.000
Z70.9 Sex counselling, unspecified
0.003 0.997 0.000
Z70.8 Other sex counselling
0.003 0.997 0.000
Z70.3 Counselling related to combined concerns regarding sexual attitude, behaviour and orientation
0.003 0.997 0.000
Z70.2 Counselling related to sexual behaviour and orientation of third party
0.003 0.997 0.000
Z70.0 Counselling related to sexual attitude
0.003 0.997 0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere
0.000 0.997 0.003
H45.1 Endophthalmitis in diseases classified elsewhere
0.000 0.997 0.003
H45.0 Vitreous haemorrhage in diseases classified elsewhere
0.000 0.997 0.003
M43.62 Torticollis-Cervical
0.003 0.997 0.000
Q43.9 Congenital malformation of intestine, unspecified
0.000 0.997 0.003
T51.0 Ethanol
0.003 0.997 0.000
D37.2 Small intestine
0.003 0.997 0.000
F12.1 Harmful use
0.003 0.997 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.003 0.997 0.000
M43.28 Other fusion of spine (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M43.27 Other fusion of spine (Lumbosacral region)
0.003 0.997 0.000
M43.25 Other fusion of spine (Thoracolumbar region)
0.003 0.997 0.000
M43.24 Other fusion of spine (Thoracic region)
0.003 0.997 0.000
M43.23 Other fusion of spine (Cervicothoracic region)
0.003 0.997 0.000
M43.22 Other fusion of spine (Cervical region)
0.003 0.997 0.000
M43.21 Other fusion of spine (Occipito-atlanto-axial region)
0.003 0.997 0.000
M43.20 Other fusion of spine (Multiple sites in spine)
0.003 0.997 0.000
M43.69 Torticollis-Site unspe
0.003 0.997 0.000
M43.68 Torticollis-Sacral/sacrococ
0.003 0.997 0.000
M43.67 Torticollis-Lumbosacral
0.003 0.997 0.000
M43.66 Torticollis-Lumbar
0.003 0.997 0.000
M43.65 Torticollis-Thoracolumbar
0.003 0.997 0.000
M43.64 Torticollis-Thoracic
0.003 0.997 0.000
M43.63 Torticollis-Cervicothoracic
0.003 0.997 0.000
M43.61 Torticollis-Occipit-atl-axl
0.003 0.997 0.000
M43.60 Torticollis-Mult site
0.003 0.997 0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)
0.000 0.997 0.003
Q44.6 Cystic disease of liver
0.000 0.997 0.003
M43.39 Recurrent atlantoaxial subluxation with myelopathy (Site unspecified)
0.003 0.997 0.000
M43.38 Recurrent atlantoaxial subluxation with myelopathy (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M43.37 Recurrent atlantoaxial subluxation with myelopathy (Lumbosacral region)
0.003 0.997 0.000
M43.36 Recurrent atlantoaxial subluxation with myelopathy (Lumbar region)
0.003 0.997 0.000
M43.35 Recurrent atlantoaxial subluxation with myelopathy (Thoracolumbar region)
0.003 0.997 0.000
M43.34 Recurrent atlantoaxial subluxation with myelopathy (Thoracic region)
0.003 0.997 0.000
M43.33 Recurrent atlantoaxial subluxation with myelopathy (Cervicothoracic region)
0.003 0.997 0.000
M43.32 Recurrent atlantoaxial subluxation with myelopathy (Cervical region)
0.003 0.997 0.000
M43.31 Recurrent atlantoaxial subluxation with myelopathy (Occipito-atlanto-axial region)
0.003 0.997 0.000
M43.30 Recurrent atlantoaxial subluxation with myelopathy (Multiple sites in spine)
0.003 0.997 0.000
M43.49 Other recurrent atlantoaxial subluxation-Site unspe
0.003 0.997 0.000
M43.48 Other recurrent atlantoaxial subluxation-Sacral/sacrococ
0.003 0.997 0.000
M43.47 Other recurrent atlantoaxial subluxation-Lumbosacral
0.003 0.997 0.000
M43.46 Other recurrent atlantoaxial subluxation-Lumbar
0.003 0.997 0.000
M43.45 Other recurrent atlantoaxial subluxation-Thoracolumbar
0.003 0.997 0.000
M43.44 Other recurrent atlantoaxial subluxation-Thoracic
0.003 0.997 0.000
M43.43 Other recurrent atlantoaxial subluxation-Cervicothoracic
0.003 0.997 0.000
M43.42 Other recurrent atlantoaxial subluxation-Cervical
0.003 0.997 0.000
M43.41 Other recurrent atlantoaxial subluxation-Occipit-atl-axl
0.003 0.997 0.000
M43.40 Other recurrent atlantoaxial subluxation-Mult site
0.003 0.997 0.000
M43.59 Other recurrent vertebral subluxation (Site unspecified)
0.003 0.997 0.000
M43.58 Other recurrent vertebral subluxation (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M43.57 Other recurrent vertebral subluxation (Lumbosacral region)
0.003 0.997 0.000
M43.56 Other recurrent vertebral subluxation (Lumbar region)
0.003 0.997 0.000
M43.55 Other recurrent vertebral subluxation (Thoracolumbar region)
0.003 0.997 0.000
M43.54 Other recurrent vertebral subluxation (Thoracic region)
0.003 0.997 0.000
M43.53 Other recurrent vertebral subluxation (Cervicothoracic region)
0.003 0.997 0.000
M43.52 Other recurrent vertebral subluxation (Cervical region)
0.003 0.997 0.000
M43.51 Other recurrent vertebral subluxation-Occipit-atl-axl
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.